#Peripheral Vascular Devices Market

[prachicmi2]

Peripheral Vascular Devices Market to Expand on Market Opportunities

The Global Peripheral Vascular Devices Market is estimated to be valued at USD 13.51 Bn in 2025 and is expected to exhibit a CAGR of 6.5% over the forecast period 2025 to 2032.

The peripheral vascular devices market encompasses a diverse range of minimally invasive medical instruments including stents, catheters, guidewires, balloon angioplasty devices, atherectomy systems and embolic protection filters. These devices facilitate diagnosis and treatment of peripheral artery disease by restoring blood flow to ischemic limbs and reducing the risk of critical limb ischemia. Advantages such as shorter hospital stays, faster patient recovery, reduced procedural risk and enhanced quality of life have driven adoption among healthcare professionals. Peripheral Vascular Devices Market Insights with the rising prevalence of diabetes, obesity and an aging population, there is an urgent need for advanced products that address challenges like restenosis and thrombosis. Recent market research highlights the integration of drug-eluting balloons, polymer-coated stents and AI-powered imaging solutions, offering improved procedural precision and long-term patency. Get more insights on,Peripheral Vascular Devices Market

[poonamcmi]

Peripheral Vascular Devices Market is Estimated to Witness High Growth Owing to Rising Geriatric Population

Peripheral vascular devices are used for the treatment and diagnosis of peripheral artery diseases. These devices help in plaque removal, angioplasty and stenting which restore smooth blood flow to limbs. The rising prevalence of peripheral artery diseases due to diabetes, obesity and high blood pressure has fueled the demand for peripheral vascular devices. Peripheral vascular devices include angioplasty balloons, stents, catheters, arterial sheaths, guidewires and other devices. Technologically advanced devices with enhanced safety, efficacy and ease of installation have gained traction in the recent years.

The global peripheral vascular devices market is estimated to be valued at US$ 12.68 Bn in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031.

Key Takeaways Key players operating in the peripheral vascular devices are Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG., Teleflex Medical, Koninklijke Philips N.V., Cardio Flow, Inc. Key players are focusing on new product launches, mergers and acquisitions to strengthen their market presence.

The rising geriatric population prone to peripheral artery diseases and growing preference for minimally invasive surgeries offer significant growth opportunities for players in the Peripheral Vascular Devices Market Size Furthermore, expanding healthcare infrastructure and increasing healthcare expenditure in emerging economies is also expected to fuel the adoption of peripheral vascular devices globally over the forecast period.

Market Drivers The rising geriatric population is one of the key drivers of the peripheral vascular devices market. According to the UN data, the world’s population aged 60 years and above is projected to double from 12% to 22% between 2015 and 2050. The elderly are more susceptible to developing peripheral artery diseases owing to reduced blood circulation and weakening of arteries with age. This is expected to significantly drive the demand for peripheral vascular devices over the next few years.

PEST Analysis

Political: Peripheral Vascular Devices Market Size And Trends are subject to extensive government regulations resulting from stringent FDA approvals for new products and procedures. Regulations impact product development timelines and costs.

Economic: Growth in the peripheral vascular devices market is driven by rising healthcare expenditure, growing elderly population suffering from peripheral vascular diseases, and favorable reimbursement policies for life-saving procedures.

Social: Increasing awareness about peripheral vascular diseases and availability of advanced treatment options encourage people to seek medical care. Sedentary lifestyles and obesity rates also contribute to the patient volumes.

Technological: Innovation leads to the development of novel drug-eluting, bioresorbable, and nano-technology based stents that reduce in-stent re-stenosis rates. Robotics, AI, and 3D printing are enhancing surgical precision and customization.

Market value concentration by geographical regions: North America accounts for the largest share of the overall peripheral vascular devices market in terms of value, owing to the high usage of advanced equipment, growing number of vascular surgeries, and supportive insurance system. Asia Pacific is expected to witness the fastest value growth over the forecast period, with expanding healthcare infrastructure and increasing medical tourism from other regions.

Fastest growing regional market: Asia Pacific peripheral vascular devices market exhibits immense growth potential attributed to the rising awareness, healthcare reforms, and willingness to adopt modern treatments. Factors like growing elderly population, increasing obesity prevalence, presence of contract manufacturers and emerging economies propel the regional market growth at a rapid rate. Get More Insights On, Peripheral Vascular Devices Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[mitalipingale]

https://community.wongcw.com/blogs/786214/Peripheral-Vascular-Devices-Market-Size-Overview-Share-and-Forecast-2031

The Peripheral Vascular Devices Market in 2023 is US$ 11.47 billion, and is expected to reach US$ 17.63 billion by 2031 at a CAGR of 5.50%.

[healthchat]

Varicose Veins Treatment in Karimnagar

At Karimnagar, we understand that every patient is unique, which is why we take a personalized approach to each individual's care plan. We offer a comprehensive range of services, including routine foot care, wound care, vascular ultrasounds, and more, to help diagnose and treat a variety of conditions. Our state-of-the-art facility is equipped with the latest technology and equipment to ensure that you receive the best possible care.

Glue Treatment For Varicose Veins in Karimnagar Glue Treatment For Varicose Veins: Glue treatment, also known as VenaSeal, is a minimally invasive treatment for varicose veins. It involves the use of a medical adhesive, which is injected into the affected vein. The glue seals the vein, and blood is rerouted to healthier veins. The procedure is painless and requires no anesthesia.

Laser Treatment For Varicose Veins in Karimnagar Laser Treatment For Varicose Veins:Laser treatment is another minimally invasive procedure used to treat varicose veins. It involves the use of a laser to heat and seal the affected vein, causing it to collapse and eventually fade away. The procedure is performed under local anesthesia, and most patients can return to normal activities within a day.

Microsclerotherapy Treatment in Karimnagar Microsclerotherapy for Cosmetic Purpose:Microsclerotherapy is a cosmetic treatment used to remove spider veins or small varicose veins. It involves the injection of a sclerosing agent directly into the affected vein, causing it to collapse and fade away. The procedure is minimally invasive and requires no anesthesia.

Peripheral Artery Bypass Treatment in Karimnagar Peripheral Artery Bypass/Angioplasty/Stenting:Peripheral artery bypass, angioplasty, and stenting are procedures used to treat peripheral artery disease. They involve the use of a catheter to insert a balloon or stent into the blocked artery, allowing blood flow to be restored. The procedure is performed under local anesthesia and requires a short hospital stay.

Aortic Aneurysm center in Karimnagar Aortic Aneurysm Stenting/Open Surgery:Aortic aneurysm stenting and open surgery are procedures used to treat an aneurysm in the aorta. Stenting involves the insertion of a stent into the weakened section of the artery to support and reinforce it. Open surgery involves the surgical repair or replacement of the damaged portion of the artery. The procedure requires general anesthesia and a hospital stay.

Diabetic Foot Treatment in Karimnagar Diabetic Foot / Podiatric Surgery:Diabetic foot and podiatric surgery are procedures used to treat foot problems related to diabetes. They involve the removal of damaged tissue, the correction of deformities, and the treatment of infections. The procedures may be performed under local or general anesthesia, depending on the complexity of the surgery.

Day Care Surgeries in Karimnagar Day Care Surgeries:Day care surgeries are minor procedures that can be performed in an outpatient setting. They include procedures such as skin biopsies, mole removal, and minor laceration repairs. The procedures are performed under local anesthesia and patients can return home the same day.

Varicose vein treatment in Karimnagar Varicose vein treatment by Endovenous Ablation: Our clinic offers a minimally invasive treatment option for varicose veins known as endovenous ablation. This treatment is performed using a laser or radiofrequency energy to heat and close the affected veins, allowing blood to reroute through healthier veins. The procedure is quick, effective, and virtually painless with no scarring, allowing patients to return to their daily activities almost immediately.

Diabetic foot ulcers and Non-healing ulcer Management in Karimnagar Diabetic foot ulcers and Non-healing ulcer Management: Our clinic specializes in the management of diabetic foot ulcers and non-healing ulcers. Our expert team of vascular surgeons offers comprehensive treatment options to promote wound healing and prevent further complications. We use a multidisciplinary approach, including wound care, offloading, infection control, and vascular interventions to help patients recover quickly.

Peripheral bypasses, DVT management in Karimnagar Peripheral bypasses, DVT management: We offer advanced treatment options for peripheral arterial disease and deep vein thrombosis. Peripheral bypass surgery involves redirecting blood flow around a blocked artery using a graft, and we provide expert care for this procedure. Our team also offers specialized care for deep vein thrombosis, including anticoagulation therapy, compression stockings, and thrombectomy if necessary.

Aortic Aneurysm Treatment in Karimnagar Aortic Aneurysm Endovascular repair: Our clinic provides endovascular repair for aortic aneurysms, a less invasive alternative to traditional open surgery. The procedure involves inserting a stent-graft through a small incision, allowing us to repair the aneurysm without major surgery. This procedure offers faster recovery times, less pain, and fewer complications than traditional open surgery.

for more info:

[drsumitblog]

The Hidden Dangers of Peripheral Arterial Disease

Peripheral Arterial Disease (PAD) often lurks unnoticed, overshadowed by more commonly discussed health issues. Yet, its impact on the circulatory system and overall health is profound. Dr. Sumit Kapadia, a renowned name in vascular health, delves into the hidden dangers and lesser-known symptoms of this disease.

Understanding PAD

PAD is a condition marked by the narrowing of arteries in the legs due to atherosclerosis. This plaque buildup hampers blood flow, leading to a range of symptoms. While leg pain during physical activities is a known symptom, PAD also manifests in subtler signs like temperature changes in the legs, skin colour changes, slower growth of toenails, and even erectile dysfunction in men, especially those with diabetes.

The Importance of Early Detection

With advancements in medical science, including new treatments for PAD in 2023, recognizing these symptoms early has become crucial. Dr. Kapadia utilizes several diagnostic tests such as the Ankle-Brachial Index (ABI) and Doppler Ultrasound Imaging, which are instrumental in detecting PAD early and preventing its progression.

Conclusion

Understanding and recognizing the lesser-known symptoms of PAD are vital for early intervention. With advanced peripheral artery disease treatment and angioplasty options available, effectively managing PAD under the guidance of experts like Dr. Kapadia is more achievable than ever.

[nainad123]

Global sales of peripheral vascular devices are expected to increase at a CAGR of 4.5% from 2023 to 2033 and reach a market size of US$ 16.83 billion by the end of the forecast period, as per this new industry analysis by Fact.MR, a market research and competitive intelligence provider.

[visionhealthandcare]

Is vascular health entering a new era of device-driven treatment breakthroughs

Why is vascular disease becoming one of the biggest global health concerns Cardiovascular diseases remain the leading cause of death worldwide, but it’s not just about heart attacks anymore. Peripheral artery disease, deep vein thrombosis, and other circulatory issues in limbs and organs are becoming increasingly common—especially among aging populations, diabetics, and smokers. As a result, the Peripheral Vascular Device Market is witnessing a major surge, driven by demand for minimally invasive, effective, and fast-acting treatment solutions.

What exactly do peripheral vascular devices do These medical tools are used to diagnose and treat blockages or damage in blood vessels outside the heart and brain. Think stents, angioplasty balloons, catheters, filters, grafts, and imaging systems that help restore proper blood flow. They’re used in everything from outpatient procedures to life-saving surgeries—offering hope to patients with critical limb ischemia, varicose veins, or compromised kidney function.

How is artificial intelligence reshaping vascular device technology Innovations in the Italy Healthcare Artificial Intelligence AI Market are now being applied to vascular care. AI-powered imaging systems allow doctors to identify plaque build-up and vessel abnormalities more accurately and earlier than ever before. Machine learning algorithms are even being used to predict procedural success, personalize stent sizing, and guide robotic-assisted interventions.

Can therapies like light treatment complement vascular healing Interestingly, findings from the Germany Light Therapy Market suggest that red and near-infrared light may support wound healing and inflammation reduction—especially in patients with poor circulation or diabetic ulcers. While not a replacement for surgical devices, light therapy is emerging as a complementary treatment for vascular complications.

What factors are fueling rapid global adoption of these technologies The rise in diabetes, hypertension, and obesity—especially in developing countries—is driving an uptick in peripheral vascular conditions. At the same time, improved access to advanced healthcare facilities and skilled professionals is making device-based interventions more common. Demand is particularly strong in aging populations across North America, Europe, and Asia-Pacific.

Which innovations are standing out in the field of vascular care Drug-coated balloons, bioresorbable stents, and hybrid catheters are redefining treatment possibilities. Some devices now combine imaging and therapy in a single platform, reducing procedure times and improving outcomes. Meanwhile, 3D-printed grafts and smart materials that adapt to blood flow are moving from research to reality.

Are there risks or limitations that still need attention Yes—device failure, blood clots, and restenosis (vessel re-narrowing) remain major concerns. Moreover, some patients with complex vascular anatomy or comorbidities may not be ideal candidates for standard devices. The industry is working toward more customized, patient-specific solutions through better diagnostics and modular designs.

How are healthcare systems responding to this growing need Hospitals are investing in vascular centers of excellence, and governments are increasingly approving fast-track reimbursements for device-based procedures. Preventive screening for vascular issues is becoming part of routine care in many countries. Training programs for surgeons are also being expanded to support adoption of these newer, less invasive techniques.

The Peripheral Vascular Device Market stands at the intersection of necessity and innovation. As more patients seek relief from debilitating vascular conditions, these devices are becoming essential—not just for treatment, but for preserving limbs, improving mobility, and extending lives. With AI enhancements and supportive technologies like light therapy on the horizon, the future of vascular health looks more precise, predictive, and personalized than ever before.

[ajinkya-2012]

Peripheral Vascular Device Market

[mitalipingale]

https://www.xaphyr.com/blogs/683982/Peripheral-Vascular-Devices-Market-Size-Overview-Share-and-Forecast-2031

The Peripheral Vascular Devices Market in 2023 is US$ 11.47 billion, and is expected to reach US$ 17.63 billion by 2031 at a CAGR of 5.50%.

[graphicabhi]

ROMVIMZA Approval Ignites Head-to-Head Race with TURALIO in Tenosynovial Giant Cell Tumor (TGCT) Market

The therapeutic landscape for tenosynovial giant cell tumor (TGCT) is heating up as Ono Pharmaceutical’s newly approved ROMVIMZA goes head-to-head with Daiichi Sankyo’s well-established TURALIO. With the recent U.S. Food and Drug Administration (FDA) approval of ROMVIMZA, Ono Pharmaceutical has cemented its position in the oral treatment segment of TGCT. Developed by Nebula Synox, ROMVIMZA aims to directly target the disease origin, providing patients a viable alternative to surgical intervention. Its unique ROMVIMZA mechanism of action (ROMVIMZA moa) offers new possibilities for those seeking non-invasive treatment options.

Discover breakthrough TGCT treatments now - learn more at: https://www.delveinsight.com/blog/romvimza-for-tgct?utm_source=blog&utm_medium=promotion&utm_campaign=akpr 

On the other side, Daiichi Sankyo’s TURALIO continues to dominate as a strong contender. As an earlier FDA-approved oral therapy for TGCT, TURALIO benefits from an established reputation and clinical footprint. With a well-documented TURALIO safety profile, recommended TURALIO 250mg dosage, and comprehensive TURALIO clinical trial data, it remains a trusted option in the tenosynovial giant cell tumor community. While TURALIO efficacy is widely acknowledged, the drug's administration comes with stringent TURALIO dosing guidelines and mandatory monitoring under the TURALIO Risk Evaluation and Mitigation Strategy (REMS) program. Daiichi Sankyo also maintains brand visibility through outreach such as TURALIO patient story initiatives and ongoing TURALIO support programs.

Both ROMVIMZA manufacturer and TURALIO manufacturer are actively expanding patient access via romvimza coupon initiatives and providing clarity on insurance questions like “does Medicare cover TURALIO.” Online searches for terms like “TGCT treatment center near me” suggest growing patient engagement. Additionally, patient curiosity around questions like “is TURALIO chemo” and in-depth comparisons of TURALIO mechanism of action (TURALIO moa) versus ROMVIMZA moa continue to rise.

Compare ROMVIMZA vs. TURALIO and explore your options here: https://www.delveinsight.com/blog/romvimza-for-tgct?utm_source=blog&utm_medium=promotion&utm_campaign=akpr 

While TURALIO specialty pharmacy distribution and regular TURALIO updates keep healthcare providers informed, Ono Pharmaceutical is banking on competitive romvimza cost and simplified access pathways to attract a broader patient base. Resources such as site:www.delveinsight.com offer valuable coverage on the tenosynovial giant cell tumors market, TGCT symptoms, and updates from the India tenosynovial giant cell tumor treatment market.

As competition intensifies, industry attention also shifts to developments from other players, including deciphera pharmaceuticals news. With emerging candidates like vimseltinib on the horizon, the TGCT treatment center landscape may soon witness further disruption.

Latest Reports Offered By DelveInsight:

gential herpes market | graves disease market | hypertriglyceridemia market | japan healthcare outlook | japan healthcare outlook market | molluscum contagiosum market | myopia progression market share | netherton syndrome market | niemann pick disease type c market | orthopedic splints device market | palmoplantar pustulosis market | pancreatic neuroendocrine tumors market | pcsk9 market | peripheral arterial disease market | peripheral nerve repair devices market | peripheral spa market | peripheral vascular devices market | persistent epithelial defects market | plaque modification devices market | progressive fibrosing interstitial lung disease market

Other Reports Offered By DelveInsight:

https://www.delveinsight.com/sample-request/diabetic-gastroparesis-markethttps://www.delveinsight.com/sample-request/diabetic-hypoglycemia-epidemiology-forecast

[intelmarketresearch]

Vascular Surgery Electrosurgical Units (ESUs) Market Growth Analysis, Market Dynamics, Key Players a

Here is the HTML content for your press release about the Vascular Surgery Electrosurgical Units (ESUs) Market:

Vascular Surgery Electrosurgical Units (ESUs) Market Poised for Steady Growth, Projected to Reach $99 Million by 2032

According to a new market analysis, the global Vascular Surgery Electrosurgical Units (ESUs) market was valued at USD 69.8 million in 2024 and is projected to reach USD 99 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2025–2032). This growth is driven by increasing demand for minimally invasive vascular procedures, technological advancements, and the rising prevalence of vascular diseases worldwide.

Download FREE Sample Report

Vascular Surgery Electrosurgical Units (ESUs) Market - View in Detailed Research Report

What are Vascular Surgery Electrosurgical Units?

Vascular Surgery ESUs are specialized medical devices designed for precise tissue cutting, coagulation, and ablation during vascular procedures. These advanced systems utilize controlled electrical currents to perform delicate interventions on arteries, veins, and lymphatic vessels. The market features three main product categories: monopolar units, bipolar systems, and specialized vessel sealing devices, each offering unique benefits for different vascular surgical applications.

The evolution of these devices has been remarkable, with modern ESUs now incorporating features like real-time tissue feedback and intelligent power modulation, which have significantly improved surgical outcomes in vascular procedures ranging from angioplasties to complex bypass surgeries.

Key Market Drivers

1. Rising Prevalence of Vascular Diseases Accelerates Market Growth

The vascular surgery ESU market is experiencing strong demand due to the increasing incidence of conditions like peripheral artery disease, aortic aneurysms, and chronic venous insufficiency. Recent epidemiological data indicates that vascular diseases affect over 200 million people globally, with cases growing by approximately 5% annually. This growing patient population requires advanced surgical interventions where vascular ESUs play a critical role.

The aging global population further compounds this demand, as elderly patients are particularly susceptible to vascular conditions. With life expectancy increasing across developed nations and the population aged 65+ projected to reach 1.5 billion by 2030, the need for vascular surgical procedures and associated technologies continues to rise.

2. Technological Advancements Transform Vascular Surgery

The market is being reshaped by continuous innovation in electrosurgical technologies. Modern vascular ESUs now incorporate advanced tissue feedback mechanisms, precise power modulation algorithms, and integrated smoke evacuation systems. These technological improvements have enhanced surgical precision while minimizing collateral tissue damage—a critical requirement in delicate vascular procedures.

Recent product launches demonstrate this innovation trend, with leading manufacturers introducing units capable of delivering ultra-precise energy outputs as low as 5 watts for microvascular applications. The integration of artificial intelligence for predictive tissue response analysis represents the next frontier in vascular ESU development.

Market Challenges

Despite their clinical benefits, vascular surgery ESUs face several adoption barriers. High equipment costs ranging from $25,000 to $75,000 per unit, plus additional expenses for disposable accessories and maintenance, create significant challenges for healthcare facilities, particularly in budget-constrained regions.

The complex regulatory environment presents another hurdle, with new vascular ESU models typically requiring 12–18 months for regulatory clearance. Recent enhancements to safety standards have increased compliance costs, with manufacturers now allocating approximately 20% of development budgets to meet evolving requirements.

Additionally, the technical complexity of modern systems necessitates extensive surgeon training. This knowledge gap currently leads to underutilization of advanced features in an estimated 40% of installed units, representing a significant challenge for market optimization.

Market Opportunities

Emerging markets present substantial growth potential for vascular surgery ESU manufacturers, with healthcare infrastructure investments in these regions increasing by approximately 8% annually. Countries with expanding middle-class populations and improving healthcare access are particularly promising targets for market expansion.

The rapid growth of ambulatory surgery centers specializing in vascular procedures creates another compelling opportunity. These facilities, which now account for nearly 30% of elective vascular procedures in North America, prefer compact, multi-functional ESU solutions that optimize limited space while maintaining full clinical capabilities.

Strategic partnerships between manufacturers and academic medical centers offer a third major opportunity area. These collaborations allow for direct clinical feedback integration during product development while building brand preference among emerging vascular surgeons.

Competitive Landscape

The global vascular surgery ESUs market features a moderately consolidated competitive environment with several key players:

Medtronic leads the market with an estimated 24% revenue share

Johnson & Johnson (Ethicon) and B. Braun Melsungen AG collectively account for approximately 31%

Erbe Elektromedizin GmbH and KLS Martin are growing through specialized vascular-focused systems

Asian manufacturers like Olympus and KINDY ELECTRONIC are gaining traction with cost-competitive offerings

The competition continues to intensify as companies invest heavily in R&D for advanced vessel sealing technologies and ergonomic designs tailored to vascular surgical workflows.

Market Segmentation

By Type:

Monopole Electrosurgical Units

Bipolar Electrosurgical Units

Vessel Sealing Units

By Application:

Public Hospitals

Private Hospitals

By Technology:

Radiofrequency-based Systems

Ultrasonic Systems

Hybrid Systems

By End User:

Hospitals

Specialty Vascular Centers

Ambulatory Surgical Centers

Regional Market Insights

North America dominates the market with high adoption rates of advanced surgical technologies and strong healthcare expenditure

Europe maintains significant market share with strict CE marking requirements and harmonized medical device regulations

Asia-Pacific is the fastest-growing region, benefiting from expanding healthcare access and improving surgical infrastructure

Latin America and Middle East & Africa show promising growth potential as healthcare systems develop

Download FREE Sample Report

Vascular Surgery Electrosurgical Units (ESUs) Market - View in Detailed Research Report

Vascular Surgery Electrosurgical Units (ESUs) Market - View in Detailed Research Report

Visit more reports : 

https://intel24.hashnode.dev/composite-rubber-track-crt-market-growth-analysis-market-dynamics-key-players-and-innovations-outlook-and-forecast-2025-2032-1https://siddheshkapshikar7.wixsite.com/my-site/post/composite-rubber-track-crt-market-growth-analysis-market-dynamics-key-players-and-innovations-o-1https://www.pearltrees.com/sid7011/item724316878https://sites.google.com/view/intel-market-research/home/composite-rubber-track-crt-market-20025https://www.tumblr.com/intelmarketresearch/787950680061132801/disposable-ophthalmic-cannulas-market-growthhttps://www.bundas24.com/blogs/52872/Disposable-Ophthalmic-Cannulas-Market-Growth-Analysis-Market-Dynamics-Key-Playershttps://hallbook.com.br/blogs/631107/Disposable-Ophthalmic-Cannulas-Market-Growth-Analysis-Market-Dynamics-Key-Playershttps://logcla.com/blogs/newhttps://controlc.com/5c05d45chttps://justpaste.it/h0ak0

About Intel Market Research

Intel Market Research delivers actionable insights in technology and infrastructure markets. Our data-driven analysis leverages:

Real-time infrastructure monitoring

Techno-economic feasibility studies

Competitive intelligence across 100+ countries Trusted by Fortune 500 firms, we empower strategic decisions with precision. International: +1(332) 2424 294 | Asia: +91 9169164321

Website: https://www.intelmarketresearch.com

Follow us on LinkedIn: https://www.linkedin.com/company/intel-market-research

[nainad123]

Global sales of peripheral vascular devices are expected to increase at a CAGR of 4.5% from 2023 to 2033 and reach a market size of US$ 16.83 billion by the end of the forecast period, as per this new industry analysis by Fact.MR, a market research and competitive intelligence provider.